MyMD Pharmaceuticals Inc (MYMD)

[knuts4oe]

MYMD is up .32 @ 9.08 in the aftermarket. Also, 50 Feb. 18, 2022 option contracts to purchase MYMD @ $10.00 traded today @ $1.50.

I have come to the conclusion that MyMD is waiting for the publication of the results of Johns Hopkins' Dr. Caturegli's study on the life extension and maintained muscle strength of mice treated with MYMD-1, before beginning the expected study of humans also to be treated with MYMD-1.

In that study 54 mice, in 3 groups of 18 mice were treated, 1 group with MYMD-1, 1 group w/ rapamycin, and 1 group with rapamycin and metformin, both of which have life extension characteristics. The mice were all treated from the human equivalent age of 58 to 85, at which point all of the 36 mice receiving rapamycin and rapamycin/metformin had died, but a goodly number, (that number not yet released), of the mice receiving MYMD-1 were still alive and strong!

Wall Street's Ray Blanco has dubbed them the "immortal mice", which is unfortunate because they are far from "immortal", and it demeans the seriousness of the results.